INCYTE CORP Annual Deferred Federal Income Tax Expense (Benefit) in USD from 2020 to 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Incyte Corp annual Deferred Federal Income Tax Expense (Benefit) history and growth rate from 2020 to 2023.
- Incyte Corp annual Deferred Federal Income Tax Expense (Benefit) for 2023 was -$139M, a 325% decline from 2022.
- Incyte Corp annual Deferred Federal Income Tax Expense (Benefit) for 2022 was $62.1M.
- Incyte Corp annual Deferred Federal Income Tax Expense (Benefit) for 2021 was -$408M.
Deferred Federal Income Tax Expense (Benefit), Annual (USD)
Deferred Federal Income Tax Expense (Benefit), YoY Annual Growth (%)